新功能、新界面、新体验,扫描即可下载生物谷APP!
首页 » BIOON报道 » 合约研究机构Psi进军印度市场

合约研究机构Psi进军印度市场

来源:生物谷 2013-08-30 20:46

2013年8月30日讯 /生物谷BIOON/ --瑞士合约研究机构Psi公司开始进入印度研究机构市场以继续拓展全球市场。公司继上个月进入南非后决定在印度班加罗尔开设分部以适应印度市场。在印度当地医药开发研究市场工作多年的Radhika Bobba将担任CEO。Psi公司目前在全球有3000多名员工。(生物谷Bioon.com)

详细英文报道:

Switzerland's Psi is reaching into India's clinical research market, opening up shop in the country and continuing its global expansion.

The CRO is setting up in Bangalore in response to client demand, Psi said, a move that follows last month's move into South Africa and 2012's leaps into North and South America, the company said. Radhika Bobba, who will lead Psi's new Asian headquarters, is an 18-year veteran of the local clinical research industry.

"This expansion is already showing tangible results in strengthening Psi's unique ability to deliver high-quality, on-time clinical studies worldwide," Bobba said in a statement.

Psi employs about 1,300 people around the world, and the CRO has been setting up satellite centers in global clinical research hubs over the past year, including offices in the Bay Area, Eastern Europe, the Middle East and, now, fast-growing Southeast Asia.

 

温馨提示:87%用户都在生物谷APP上阅读,扫描立刻下载! 天天精彩!


相关标签

最新会议 培训班 期刊库